2-bromo-4-cyclopentyloxy-3-(4-nitrophenoxy)benzaldehyde

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-bromo-4-cyclopentyloxy-3-(4-nitrophenoxy)benzaldehyde
• 英文别名: 2-bromo-4-cyclopentoxy-(3-p-nitrophenoxy)-benzaldehyde；2-bromo-4-cyclopentoxy-3-(4-nitrophenoxy) benzaldehyde；2-Bromo-4-cyclopentoxy-3-(p-nitrophenoxy)-benzaldehyde
• 化学式: C₁₈H₁₆BrNO₅
• 分子量: 406.233
• InChiKey: HOHRWGONSXMWRK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  25
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  81.4
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-bromo-4-cyclopentyloxy-3-(4-nitrophenoxy)benzaldehyde 在 palladium diacetate sodium tetrahydroborate 、 氯化亚砜 、 苄基三甲基氢氧化铵 、 sodium hydride 、 sodium carbonate 作用下， 以 四氢呋喃 、 乙二醇二甲醚 、 二氯甲烷 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 27.33h， 生成 5-cyano-5-(4-cyclopentyloxy-8-nitro-dibenzofuran-1-yl)-2-oxo-cyclohexane carboxylic acid methyl ester
  参考文献：
  名称：

  [EN] NOVEL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION
  [FR] NOUVEAUX COMPOSÉS HÉTÉROCYCLIQUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET PROCÉDÉS POUR LEUR PRÉPARATION

  摘要：

  公开号：

  WO2009115874A3
• 作为产物：
  描述：

  4-cyclopentyloxy-3-hydroxybenzaldehyde 在 溴 、 sodium acetate 、 铁粉 、 potassium carbonate 、 溶剂黄146 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 6.0h， 生成 2-bromo-4-cyclopentyloxy-3-(4-nitrophenoxy)benzaldehyde
  参考文献：
  名称：

  [EN] NOVEL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION
  [FR] NOUVEAUX COMPOSÉS HÉTÉROCYCLIQUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET PROCÉDÉS POUR LEUR PRÉPARATION

  摘要：

  公开号：

  WO2009115874A3

文献信息

• [EN] NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] NOUVEAUX COMPOSES TRICYCLIQUES UTILES POUR TRAITER LES TROUBLES INFLAMMATOIRES ET ALLERGIQUES, PROCEDE DE PREPARATION DE CES COMPOSES ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
  申请人：GLENMARK PHARMACEUTICALS LTD

  公开号：WO2004037805A1

  公开（公告）日：2004-05-06

  The present invention relates to novel tricyclic compounds useful for the treatment of inflammatory conditions, diseases of the central nervous and insulin resistant diabetes.

  本发明涉及用于治疗炎症性疾病、中枢神经系统疾病和胰岛素抵抗性糖尿病的新型三环化合物。
• Synthesis of multi-substituted dibenzo[<i>b,d</i>]furan
  作者：Jitendra M. Gajera、Balasubramanian Gopalan、Pravin S. Yadav、Sandip D. Patil、Laxmikant A. Gharat

  DOI：10.1002/jhet.5570450326

  日期：2008.5

  The synthesis of multi-substituted dibenzo[b,d]furan derivatives 7a-b and 11a-b from readily available starting materials is described. These compounds are important intermediates for synthesis of molecules having wide therapeutic applications.

  描述了由容易获得的起始原料合成多取代的二苯并[ b，d ]呋喃衍生物7a-b和11a-b。这些化合物是用于合成具有广泛治疗应用的分子的重要中间体。
• [EN] NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] NOUVEAUX COMPOSES HETEROCYCLIQUES POUR LE TRAITEMENT DES AFFECTIONS INFLAMMATOIRES ET ALLERGIQUES, LEUR PROCEDE DE PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
  申请人：GLENMARK PHARMACEUTICALS LTD

  公开号：WO2004089940A1

  公开（公告）日：2004-10-21

  The present invention relates to novel heterocyclic compounds, their analogs, their tautomers, their regioisomers, their stereoisomers, their enantiomers, their diastereomers, their polymorphs, their pharmaceutically acceptable salts, their appropriate N-oxides, their pharmaceutically acceptable solvates and their pharmaceutical compositions containing them. The present invention more particularly relates to novel Phosphodiesterase type 4 (PDE4) inhibitors of the formula (1), their analogs, their tautomers, their enantiomers, their diasteromers, their regioisomers, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their appropriate N-oxide, their pharmaceutically acceptable solvates and the pharmaceutical compositions containing them. The groups X, Ar, Y, P and R1-R4 are defined in claim 1.

  本发明涉及新颖的杂环化合物，它们的类似物，其互变异构体，其位置异构体，其立体异构体，其对映异构体，其二对映异构体，其多晶形式，其药用可接受盐，其适当的N-氧化物，其药用可接受溶剂和含有它们的药物组合物。本发明更具体地涉及公式（1）的新型磷酸二酯酶4型（PDE4）抑制剂，其类似物，其互变异构体，其对映异构体，其二对映异构体，其位置异构体，其立体异构体，其多晶形式，其药用可接受盐，其适当的N-氧化物，其药用可接受溶剂和含有它们的药物组合物。其中，X、Ar、Y、P 和 R1-R4 组在权利要求书中有定义。
• Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
  申请人：Glenmark Pharmaceuticals, S.A.

  公开号：US07393846B2

  公开（公告）日：2008-07-01

  The present invention relates to novel heterocyclic compounds, their analogs, their tautomers, their regioisomers, their stereoisomers, their enantiomers, their diastereomers, their polymorphs, their pharmaceutically acceptable salts, their appropriate N-oxides, their pharmaceutically acceptable solvates and their pharmaceutical compositions containing them. The present invention more particularly relates to novel Phosphodiesterase type 4 (PDE4) inhibitors of the Formula (1), their analogs, tautomers, enantiomers, diasteromers, regioisomers, stereoisomers, polymorphs, pharmaceutically acceptable salts, appropriate N-oxide, pharmaceutically acceptable solvates and the pharmaceutical compositions containing them.

  本发明涉及新型杂环化合物及其类似物、互变异构体、位置异构体、立体异构体、对映异构体、二对映异构体、多晶型、药学上可接受的盐、适当的N-氧化物、药学上可接受的溶剂化物和含有它们的制药组合物。本发明更具体地涉及公式（1）的新型磷酸二酯酶4（PDE4）抑制剂及其类似物、互变异构体、对映异构体、二对映异构体、位置异构体、立体异构体、多晶型、药学上可接受的盐、适当的N-氧化物、药学上可接受的溶剂化物和含有它们的制药组合物。
• SYNTHESIS OF HETEROCYCLIC COMPOUNDS
  申请人：Araldi Gian-Luca

  公开号：US20080009632A1

  公开（公告）日：2008-01-10

  Methods for the synthesis of heterocyclic compounds including N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide and pharmaceutically acceptable salts thereof.

  合成含有N-(3,5-二氯吡啶-4-基)-4-二氟甲氧基-8-甲磺酰氨基二苯并[b,d]呋喃-1-羧酰胺和其药学上可接受的盐的杂环化合物的方法。